Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to ...

Mountford, now 23, was sentenced to 12 months' detention in a young offender institution in November 2021, but he continued ...

On searching the vehicle, firearms officers recovered a small axe and two knives along with a quantity of prescription drugs ...

ADC payload with a differentiated mechanism of actionCombines oncology expertise of Novartis with Myricx Bio’s novel ADC assets and platform having broad potential across multiple solid tumour ...

Adds potential first-in-class,N-myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform, designed to address resistance to current payloads Strengthens the Novartis ...

Dr. Kyaw Zin Thein was in the middle of a difficult conversation. His patient — a man in his 70s — was running out of options ...

When I asked him what he thought was wrong with me, he offered two diagnoses: major depressive disorder and generalized ...

The U.S. Food and Drug Administration has classified the recall of certain types of Zapp's and Dirty brand potato chips as ...

Investors are growing more optimistic over the company's pipeline and the initiation of a Phase 1 trial with a new drug.

Objective To investigate the association between attention-deficit/hyperactivity disorder (ADHD) and cardiometabolic risk profile at the time of type 2 diabetes (T2D) diagnosis and examine ...

A 112,000-patient study links SGLT2 inhibitors to lower dementia risk in people with psychiatric disorders. Read what it could mean.

Objective Sarcopenia, defined by reductions in muscle mass and strength, increases the risk of adverse outcomes in patients with rheumatoid arthritis (RA)—driven in part by chronic inflammation—and is ...